This meetup will attempt to frame some of the important issues around the use of subgroup analysis in drug development and provide consideration from both a practitioner’s and regulator’s prospective.
Additional description of this event coming soon!
Confirmed peakers for this event are:
Ilya Lipkovich, (Lily)
Rob Hemmings, (Consilium Salmonson and Hemmings)
Stephen Ruberg, (Analytix Thinking)
The titles for their talks as well as connection information will be published here as the event date draws near.